发明申请
US20120289684A1 METHODS OF TREATING INFLAMMATION USING SOLUBLE IL-17RA/RC FUSION PROTEINS
审中-公开
使用可溶性IL-17RA / RC融合蛋白治疗炎症的方法
- 专利标题： METHODS OF TREATING INFLAMMATION USING SOLUBLE IL-17RA/RC FUSION PROTEINS
- 专利标题（中）： 使用可溶性IL-17RA / RC融合蛋白治疗炎症的方法
-
申请号： US13487828申请日： 2012-06-04
-
公开(公告)号： US20120289684A1公开(公告)日： 2012-11-15
- 发明人: Steven D. Levin , Mark W. Rixon , Zeren Gao
- 申请人： Steven D. Levin , Mark W. Rixon , Zeren Gao
- 申请人地址： US WA Seattle
- 专利权人： ZYMOGENETICS, INC.
- 当前专利权人： ZYMOGENETICS, INC.
- 当前专利权人地址： US WA Seattle
- 主分类号： C07K16/00
- IPC分类号： C07K16/00 ; C07K16/42
摘要：
Disclosed are antagonists of IL-17A and IL-17F. The antagonists are based on soluble IL-17RA and IL-17RC fusion proteins, including hybrid soluble receptors comprising portions of both IL-17RC and IL-17RA (“IL-17RC/IL-17RA”). Such antagonists serve to block, inhibit, reduce, antagonize or neutralize the activity of IL-17F, IL-17A, or both IL-17A and IL-17F. Also disclosed are methods of using such antagonists for treating disease, particularly inflammatory diseases mediated at least in part by IL-17A and/or IL-17F.
信息查询
